OB fusion protein compositions and methods
First Claim
Patent Images
1. A DNA sequence of SEQ ID NOS:
- 7, 8, 10, 11, 13, 14, 16, or 17 encoding a fusion protein optionally having an N-terminal methionine, said fusion protein comprising an antibody constant region or portion thereof attached to the N-terminus of a human OB protein, wherein said OB protein is selected from the group consisting of;
(a) the amino acid sequence 1-146 as set forth in SEQ ID NO;
6;
(b) the amino acid sequence 1-146 as set forth in SEQ ID NO;
6 having a lysine residue at position 35 and an isoleucine residue at position 74;
(c) the amino acid sequence of subparts (a) or (b) lacking a glutaminyl residue at position 28; and
(d) the amino acid sequence of subparts (a), (b), or (c), wherein one or more amino acids selected from the group consisting of amino acids 32, 35, 50, 64, 68, 71, 74, 77, 89, 97, 100, 105, 106, 107, 108, 111, 118, 136, 138, 142 and 145 is substituted with the corresponding amino acid present in SEQ ID NO;
3 or a conserved amino acid.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to Fc-OB fusion protein compositions, methods of preparation of such compositions and uses thereof. In particular, the present invention relates to a genetic or chemical fusion protein comprising the Fc immunoglobulin region, derivative or analog fused to the N-terminal portion of the OB protein, derivative or analog.
-
Citations
8 Claims
-
1. A DNA sequence of SEQ ID NOS:
- 7, 8, 10, 11, 13, 14, 16, or 17 encoding a fusion protein optionally having an N-terminal methionine, said fusion protein comprising an antibody constant region or portion thereof attached to the N-terminus of a human OB protein, wherein said OB protein is selected from the group consisting of;
(a) the amino acid sequence 1-146 as set forth in SEQ ID NO;
6;
(b) the amino acid sequence 1-146 as set forth in SEQ ID NO;
6 having a lysine residue at position 35 and an isoleucine residue at position 74;
(c) the amino acid sequence of subparts (a) or (b) lacking a glutaminyl residue at position 28; and
(d) the amino acid sequence of subparts (a), (b), or (c), wherein one or more amino acids selected from the group consisting of amino acids 32, 35, 50, 64, 68, 71, 74, 77, 89, 97, 100, 105, 106, 107, 108, 111, 118, 136, 138, 142 and 145 is substituted with the corresponding amino acid present in SEQ ID NO;
3 or a conserved amino acid. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
- 7, 8, 10, 11, 13, 14, 16, or 17 encoding a fusion protein optionally having an N-terminal methionine, said fusion protein comprising an antibody constant region or portion thereof attached to the N-terminus of a human OB protein, wherein said OB protein is selected from the group consisting of;
Specification